Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Black article on Phase 2 Trial of Atezolizumab

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Aug 24, 2023 4:19pm

124 Views

Post# 35604335

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Keep in mind we have been fast track designated and that allowed special Privileges so we could meet with the FDA making sure we were ready to apply for BTD

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario